Huntington's Disease Clinical Trials Corner: November 2022

In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the PIVOT HD (PTC518), and SIGNAL (pepinemab) trials, and list all currently registered and ongoing clinical trials in Huntington's disease. We also introduce a `breaking news' section highlighting recent updates about the SELECT HD, uniQure AMT-130, and VIBRANT HD clinical trials.

Automated summary

This article provides an in-depth overview of the PIVOT HD and SIGNAL trials in Huntington's disease, along with a comprehensive list of all currently registered and ongoing clinical trials. It also includes a "breaking news" section highlighting recent updates on the SELECT HD, uniQure AMT-130, and VIBRANT HD clinical trials.